Clinical trials
Phase 1/2 Colorectal Neoplasms trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 50 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 4 |
| Aronex Pharmaceuticals | 2 |
| China Medical University, China | 2 |
| Chinese Academy of Medical Sciences | 2 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2 |
| Radboud University Medical Center | 2 |
| Academic and Community Cancer Research United | 1 |
| Chinese PLA General Hospital | 1 |
| Chong Kun Dang Pharmaceutical | 1 |
| East and North Hertfordshire NHS Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 50 |
| Pancreatic Neoplasms | 8 |
| Carcinoma, Hepatocellular | 7 |
| Stomach Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Colonic Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Carcinoma, Renal Cell | 4 |
| Melanoma | 4 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.